Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 4/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28858703 | 0.83 | ADH1B (0.30) | — | |
| SCHEMBL17416331 | 0.79 | ADH1B (0.30) | — | |
| SCHEMBL15327593 | 0.76 | SLC1A3 (0.38) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL7210373 | 0.75 | SLC1A3 (0.37) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT | |
| SCHEMBL1196065 | 0.75 | SLC1A3 (0.39) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT | |
| SCHEMBL1195466 | 0.75 | SLC1A3 (0.39) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT | |
| SCHEMBL6675517 | 0.75 | SLC1A3 (0.39) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT | |
| SCHEMBL4272520 | 0.72 | ADH1B (0.34) | — | |
| SCHEMBL17245264 | 0.69 | MMP1 (0.43) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT | |
| SCHEMBL17245265 | 0.69 | MMP1 (0.43) | SLC1A3SLC1A2SLC1A1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6344452-B1 | GASTRIN RECEPTOR ANTAGONIST, GASTROINTESTINAL DISORDERS, ETC | ZERIA PHARMACEUTICALS CO., LTD. (JP) | 2002-02-05 | — | — | US | disclosed |
| EP-1085014-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | Zeria Pharmaceutical Co., Ltd. (JP) | 2001-03-21 | — | — | EP | disclosed |